• Home
  • NEW DAY MEDICINE
  • 1 (87) 2026
  • 57 -1 (87) 2026 - Ataniyazov Kh.Kh., Khamidullaeva G.A. - CLINICAL AND HEMODYNAMIC CHARACTERISTICS OF COMORBID COURSE OF SALT-SENSITIVE ARTERIAL HYPERTENSION IN THE POPULATION OF THE ARAL SEA REGION

57 -1 (87) 2026 - Ataniyazov Kh.Kh., Khamidullaeva G.A. - CLINICAL AND HEMODYNAMIC CHARACTERISTICS OF COMORBID COURSE OF SALT-SENSITIVE ARTERIAL HYPERTENSION IN THE POPULATION OF THE ARAL SEA REGION

CLINICAL AND HEMODYNAMIC CHARACTERISTICS OF COMORBID COURSE OF SALT-SENSITIVE ARTERIAL HYPERTENSION IN THE POPULATION OF THE ARAL SEA REGION

Ataniyazov Kh.Kh.- Republican Specialized Cardiology Scientific and Practical Medical Center, regional branch of the Republic of Karakalpakstan

Khamidullaeva G.A. - Republican Specialized Cardiology Scientific and Practical Medical Center

Resume

In modern medicine, various diseases lose their mononosological character and acquire comorbid status. Unfavorable environmental conditions and rising morbidity, including cardiovascular diseases and related pathologies, in the Aral Sea region necessitate strengthening effective disease prevention measures and pharmacotherapy in primary health care facilities. Our study found that salt-sensitive hypertension in the Aral Sea region is associated with type 2 diabetes mellitus, which in turn is associated with coronary heart disease and is characterized by a significantly higher frequency of clinical, hemodynamic, and cardiovascular risk factors

Keywords: arterial hypertension, comorbidity, prevention, pharmacotherapy, ischemic heart disease, diabetes mellitus.

First page

335

Last page

340

For citation:Ataniyazov Kh.Kh., Khamidullaeva G.A. - CLINICAL AND HEMODYNAMIC CHARACTERISTICS OF COMORBID COURSE OF SALT-SENSITIVE ARTERIAL HYPERTENSION IN THE POPULATION OF THE ARAL SEA REGION//New Day in Medicine 1(87)2026 335-340 https://newdayworldmedicine.com/en/new_day_medicine/1-87-2026

List of References

  1. Демидова Т.Ю., Кисляк О.А. Особенности течения и лечение артериальной гипертензии у пациентов с сахарным диабетом 2 типа. Рациональная фармакотерапия в кардиологии. 2020;16(4):623-634. https://doi.org/10.1111/j.0954-6820.1987.tb05925.x.
  2. Игнатенко Г.А., Мухин И.В., Гавриляк В.Г., Дзюбан А.С., Коваль С.А.,Чеботарева Е.Н. Общность патогенетических механизмов формирования синтропии и их коррекция у больных сахарным диабетом 2-го типа очень высокого кардиоваскулярного риска. Университетская клиника. 2018;1(26):12-19.
  3. Литовский И.А., Гордиенко А.В. “Коморбидная связь атеросклероза, гипертонической болезни т остеопороза”. СпецЛит. Санкт-Петербург. 2020; 3-478 стр.
  4. Оганов Р.Г., Симаненков В.И., Бакулин И.Г., Бакулина Н.В., Барбараш О.Л., Бойцов С.А., Болдуева С.А., Гарганеева Н.П., Дощицин В.Л., Каратеев А.Е., Котовская Ю.В., Лила А.М., Лукьянов М.М., Морозова Т.Е., Переверзев А.П., Петрова М.М., Поздняков Ю.М., Сыров А.В., Тарасов А.В., Ткачева О.Н., Шальнова С.А. Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения. Кардиоваскулярная терапия и профилактика. 2019;18(1):5-66.
  5. Хлынова О.В., Туев А.В., Береснева Л.Н., Агафонов А.В. Проблема коморбидности с учетом состояния сердечно-сосудистой системы у пациентов с артериальной гипертензией и кислотозависимыми заболеваниями. Казанский медицинский журнал. 2013;94(1):80-85.
  6. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37-43. https://doi.org/10.1016/S0140-6736(12)60240-2.
  7. Feinstein AR. Pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases. 1970;23(7):455-468. https://doi.org/10.1016/0021-9681(70)90054-8.
  8. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. Consensus statement by the American association of clinical endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm — 2017 executive summary. Endocrine Practice. 2017;23(2):207-238. https://doi.org/10.4158/EP161682.CS.
  9. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2016;389(10064):37-55. https://doi.org/10.1016/S0140-6736(16)31919-5.

    file

    download